Invention Grant
![Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors](/docs/US/2023-08-08/US11718618B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors
-
Application No.: US18096073Application Date: 2023-01-12
-
Publication No.: US11718618B2Publication Date: 2023-08-08
- Inventor: Nicole Harriott , Nicholas Pagano , Byron A. Boon
- Applicant: Neurocrine Biosciences, Inc.
- Applicant Address: US CA San Diego
- Assignee: Neurocrine Biosciences, Inc.
- Current Assignee: Neurocrine Biosciences, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/4353
- IPC: A61K31/4353 ; C07D471/14 ; C07D471/04 ; A61P25/18
![Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors](/abs-image/US/2023/08/08/US11718618B2/abs.jpg.150x150.jpg)
Abstract:
This disclosure relates generally to VMAT2 inhibitor compounds of Formula (Ia):
and pharmaceutically acceptable salts thereof, as well as compositions and methods related thereto.
and pharmaceutically acceptable salts thereof, as well as compositions and methods related thereto.
Public/Granted literature
- US20230159528A1 VMAT2 INHIBITORS AND METHODS OF USE Public/Granted day:2023-05-25
Information query
